Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients
TRANSFUSION AND APHERESIS SCIENCE, cilt.57, sa.6, ss.752-755, 2018 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 57 Sayı: 6
- Basım Tarihi: 2018
- Doi Numarası: 10.1016/j.transci.2018.09.013
- Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.752-755
- Anahtar Kelimeler: Acute myeloid leukemia, Allogeneic stem cell transplantation, High-Dose cytarabine, ACUTE MYELOGENOUS LEUKEMIA, MAINTENANCE CHEMOTHERAPY, REMISSION, THERAPY, ADULTS, DAUNORUBICIN, SURVIVAL
- Hacettepe Üniversitesi Adresli: Evet
Özet
Background and Aim: This is a retrospective study aiming to investigate the effect of the number of high dose cytarabine-based chemotherapy (HiDAC) courses in patients with acute myeloid leukemia before allogenic stem cell transplantation (ASCT).